N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S594000

Reexamination Certificate

active

06861420

ABSTRACT:
The present invention provides compounds of Formula I:wherein X, R1, R2, R3, R4, R5, and R6have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of Formula I.

REFERENCES:
patent: 5132311 (1992-07-01), Liang
patent: 20020019389 (2002-02-01), Kim et al.
patent: WO 9748699 (1997-12-01), None
patent: WO 9748700 (1997-12-01), None
patent: WO 0195856 (2001-12-01), None
Robichaud et al. (Annual reports in Medicinal Chemistry 35, Chapter 2) 2000.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3373040

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.